Jonathan Boulais

Jonathan Boulais

Auto-generated profile, based on publicly available information

Jonathan Boulais

Institut de Recherches Cliniques de Montréal, Montréal, Canada

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2019 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
HBHalil Bagci
Halil Bagci
NSNeera Sriskandarajah
Neera Sriskandarajah
ARAmélie Robert
Amélie Robert
JBJonathan Boulais
Jonathan Boulais
IEIslam E. Elkholi
Islam E. Elkholi
JCJean-François Côté
Jean-François Côté

6 December 2006 in Nature
Verified
Journal Article
Closed access
PDF file
LSL. M. Stuart
L. M. Stuart
JBJ. Boulais
J. Boulais
GCG. M. Charriere
G. M. Charriere
EHE. J. Hennessy
E. J. Hennessy
SBS. Brunet
S. Brunet
RER. A. B. Ezekowitz
R. A. B. Ezekowitz

19 October 2010 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
JBJonathan Boulais
Jonathan Boulais
MTMatthias Trost
Matthias Trost
CLChristian R Landry
Christian R Landry
RDRégis Dieckmann
Régis Dieckmann
ELEmmanuel D Levy
Emmanuel D Levy
MDMichel Desjardins
Michel Desjardins
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 April 2008 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
IJIsabelle Jutras
Isabelle Jutras
MHMathieu Houde
Mathieu Houde
NCNathan Currier
Nathan Currier
JBJonathan Boulais
Jonathan Boulais
SDSophie Duclos
Sophie Duclos
MDMichel Desjardins
Michel Desjardins
Macrophages are immune cells that function in the clearance of infectious particles. This process involves the engulfment of microbes into phagosomes where these particles are lysed and degraded. In the current study, we used a large scale quantitative proteomics approach to analyze the changes in protein abundance induced on phagosomes by interferon-γ (IFN-γ), an inflammatory cytokine that activates macrophages. Our analysis identified 167 IFN-γ-modulated proteins on phagosomes of which more than 90% were up-regulated. The list of phagosomal proteins regulated by IFN-γ includes proteins expected to alter phagosome maturation, enhance microbe degradation, trigger the macrophage immune response, and promote antigen loading on major histocompatibility complex (MHC) class I molecules. A dynamic analysis of IFN-γ-sensitive proteins by Western blot indicated that newly formed phagosomes display a delayed proteolytic activity coupled to an increased recruitment of the MHC class I peptide-loading complex. These phagosomal conditions may favor antigen presentation by MHC class I molecules on IFN-γ-activated macrophages.

12 April 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
CVCharles Vadnais
Charles Vadnais
RCRiyan Chen
Riyan Chen
JFJennifer Fraszczak
Jennifer Fraszczak
ZYZhenbao Yu
Zhenbao Yu
JBJonathan Boulais
Jonathan Boulais
TMTarik Möröy
Tarik Möröy
GFI1 is a transcriptional regulator expressed in lymphoid cells, and an “oncorequisite” factor required for development and maintenance of T-lymphoid leukemia. GFI1 deletion causes hypersensitivity to ionizing radiation, for which the molecular mechanism remains unknown. Here, we demonstrate that GFI1 is required in T cells for the regulation of key DNA damage signaling and repair proteins. Specifically, GFI1 interacts with the arginine methyltransferase PRMT1 and its substrates MRE11 and 53BP1. We demonstrate that GFI1 enables PRMT1 to bind and methylate MRE11 and 53BP1, which is necessary for their function in the DNA damage response. Thus, our results provide evidence that GFI1 can adopt non-transcriptional roles, mediating the post-translational modification of proteins involved in DNA repair. These findings have direct implications for treatment responses in tumors overexpressing GFI1 and suggest that GFI1’s activity may be a therapeutic target in these malignancies.

17 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
AAAfnan Abu-Thuraia
Afnan Abu-Thuraia
MGMarie-Anne Goyette
Marie-Anne Goyette
JBJonathan Boulais
Jonathan Boulais
CDCarine Delliaux
Carine Delliaux
CAChloé Apcher
Chloé Apcher
JCJean-François Côté
Jean-François Côté
Aberrant expression of receptor tyrosine kinase AXL is linked to metastasis. AXL can be activated by its ligand GAS6 or by other kinases, but the signaling pathways conferring its metastatic activity are unknown. Here, we define the AXL-regulated phosphoproteome in breast cancer cells. We reveal that AXL stimulates the phosphorylation of a network of focal adhesion (FA) proteins, culminating in faster FA disassembly. Mechanistically, AXL phosphorylates NEDD9, leading to its binding to CRKII which in turn associates with and orchestrates the phosphorylation of the pseudo-kinase PEAK1. We find that PEAK1 is in complex with the tyrosine kinase CSK to mediate the phosphorylation of PAXILLIN. Uncoupling of PEAK1 from AXL signaling decreases metastasis in vivo, but not tumor growth. Our results uncover a contribution of AXL signaling to FA dynamics, reveal a long sought-after mechanism underlying AXL metastatic activity, and identify PEAK1 as a therapeutic target in AXL positive tumors.